Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point for fast-moving stocks, which can lead to investments with limited upside or potential downside [2] - A safer approach involves investing in bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify these opportunities [3] Group 2: Forestar Group (FOR) Analysis - Forestar Group (FOR) has shown a four-week price change of 2.2%, indicating growing investor interest and positioning it well in the market [4] - The stock has gained 0.6% over the past 12 weeks and has a beta of 1.42, suggesting it moves 42% more than the market in either direction, indicating strong momentum [5] - FOR has a Momentum Score of B, suggesting it is an opportune time to invest in the stock to capitalize on its momentum [6] Group 3: Earnings Estimates and Valuation - An upward trend in earnings estimate revisions has contributed to FOR earning a Zacks Rank 2 (Buy), which is associated with strong momentum effects as analysts raise earnings estimates [7] - FOR is trading at a Price-to-Sales ratio of 0.76, indicating it is relatively undervalued, as investors pay only 76 cents for each dollar of sales [7] Group 4: Additional Investment Opportunities - Besides FOR, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting further investment opportunities [8] - The Zacks Premium Screens offer over 45 different strategies to help identify potential winning stock picks based on individual investing styles [9]

Core Insights - Earth Science Tech, Inc. (ETST) reported significant financial and operational developments for the first fiscal quarter ending June 30, 2025, highlighting a strategic shift towards maximizing the value of its current divisions after a period of acquisitions [1][2]. Financial Highlights - Total assets increased by 61% to $7.69 million as of June 30, 2025, compared to $4.77 million in the prior-year period [5]. - Revenue generated was $8.7 million as of June 30, 2025, up from $8.5 million in the prior-year period [5]. - The company reduced total common shares outstanding by 4.78% to 294,297,607 as of June 30, 2025, down from 309,067,711 shares in the prior-year period [5]. - Cash and cash equivalents reported at $0.88 million, a decrease from $1.38 million in the prior-year period due to capital deployment for acquisitions [5]. Strategic and Operational Updates - ETST executed its growth strategy by acquiring 100% of Las Villas Health Care, Inc. and DOConsultation, LLC, enhancing its healthcare offerings [5]. - The company secured 80% ownership of Magnefuse, LLC, and Alicat, LLC, expanding its direct-to-consumer brand portfolio [5]. - A new customer service center was established in Doral, FL, to centralize support operations across all divisions [5]. - The company joined the OTCID Tier on the OTC Markets, improving disclosure and transparency for investors [5]. - Mister Meds, LLC is now fully operational and actively dispensing in Texas, while Avenvi, LLC has commenced its first residential development project [5].

Company Overview - Earth Science Tech, Inc. operates as a strategic holding company focused on value creation through acquisition, operational optimization, and management of its operating businesses [1] - The company's current operations include compounding pharmaceuticals, telemedicine, and real estate development through its subsidiaries [1] Financial Performance - Cash increased to $1,473,228 as of March 31, 2025, up from $697,721 as of March 31, 2024, representing a 111.15% year-over-year improvement [4] - Total assets rose to $7,066,721, compared to $3,881,336 as of March 31, 2024, marking an 82.07% year-over-year increase [4] - Revenue for the fiscal year reached $33,117,624, a significant increase from $11,953,635 for the year ended March 31, 2024, reflecting a 177.05% year-over-year growth [4] - Gross profit was reported at $24,300,136, compared to $7,828,496 for the previous year, indicating a 210.41% year-over-year improvement [4] - Net profit increased to $3,253,635, up from $812,139 for the year ended March 31, 2024, representing a 300.63% year-over-year growth [4] - Outstanding shares decreased to 295,347,903 from 309,981,819 as of March 31, 2024, a reduction of 4.72% [4] Subsidiaries and Operations - RxCompoundStore.com, LLC is a fully licensed compounding pharmacy operating in multiple states and territories, actively pursuing licensure in remaining U.S. states [2] - Mister Meds, acquired on October 1, 2024, received full compounding licensure in March 2025 and operates a facility with advanced sterile compounding capabilities [3] - Peaks Curative, LLC is a telemedicine referral platform offering consultations for compounded medications prepared at RxCompound and Mister Meds [4] - Las Villas Health Care, Inc. provides healthcare services to the Spanish-speaking community, focusing on advanced sexual health treatments [5] - Avenvi, LLC is engaged in real estate development and asset management, overseeing a $5 million share repurchase program [6] - MagneChef is a direct-to-consumer retail brand developing new cooking products utilizing its patents and intellectual properties [7]